Literature DB >> 32097458

Stem cell donors should be screened for CHIP.

Amy E DeZern1, Lukasz P Gondek1.   

Abstract

This article has a companion Counterpoint by Gibson and Lindsley.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 32097458      PMCID: PMC7042978          DOI: 10.1182/bloodadvances.2019000394

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  44 in total

1.  Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms.

Authors:  Hilda Rachel Diamond; Maria Helena Ornellas; Alberto Orfao; Bernadete E Gomes; Mércia M Campos; Teresa S Fernandez; Roberto I da Silva; Gilda Alves; Claudia Lage; Dayse A da Silva; Arthur Moellmann-Coelho; Geydson S da Cruz; Luis Fernando Bouzas; Eliana Abdelhay
Journal:  J Hematol Oncol       Date:  2011-09-27       Impact factor: 17.388

2.  Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.

Authors:  Mareike Frick; Willy Chan; Christopher Maximilian Arends; Raphael Hablesreiter; Adriane Halik; Michael Heuser; David Michonneau; Olga Blau; Kaja Hoyer; Friederike Christen; Joel Galan-Sousa; Daniel Noerenberg; Verena Wais; Michael Stadler; Kenichi Yoshida; Johannes Schetelig; Esther Schuler; Felicitas Thol; Emmanuelle Clappier; Maximilian Christopeit; Francis Ayuk; Martin Bornhäuser; Igor Wolfgang Blau; Seishi Ogawa; Tomasz Zemojtel; Armin Gerbitz; Eva M Wagner; Bernd M Spriewald; Hubert Schrezenmeier; Florian Kuchenbauer; Guido Kobbe; Markus Wiesneth; Michael Koldehoff; Gérard Socié; Nicolaus Kroeger; Lars Bullinger; Christian Thiede; Frederik Damm
Journal:  J Clin Oncol       Date:  2018-11-07       Impact factor: 44.544

3.  High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML.

Authors:  Enrico Tiacci; Alessandra Venanzi; Stefano Ascani; Andrea Marra; Valeria Cardinali; Giovanni Martino; Veronica Codoni; Gianluca Schiavoni; Maria Paola Martelli; Brunangelo Falini
Journal:  N Engl J Med       Date:  2018-09-06       Impact factor: 91.245

4.  Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.

Authors:  Max Jan; Thomas M Snyder; M Ryan Corces-Zimmerman; Paresh Vyas; Irving L Weissman; Stephen R Quake; Ravindra Majeti
Journal:  Sci Transl Med       Date:  2012-08-29       Impact factor: 17.956

5.  Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide.

Authors:  Shannon R McCurdy; Mei-Jie Zhang; Andrew St Martin; Monzr M Al Malki; Asad Bashey; Sameh Gaballa; Daniel A Keesler; Mehdi Hamadani; Maxim Norkin; Miguel-Angel Perales; Ran Reshef; Vanderson Rocha; Rizwan Romee; Melhem Solh; Alvaro Urbano-Ispizua; Edmund K Waller; Ephraim J Fuchs; Mary Eapen
Journal:  Blood Adv       Date:  2018-02-13

Review 6.  Clinical Implications of Clonal Hematopoiesis.

Authors:  David P Steensma
Journal:  Mayo Clin Proc       Date:  2018-07-04       Impact factor: 7.616

7.  Who is the best donor for a related HLA haplotype-mismatched transplant?

Authors:  Yu Wang; Ying-Jun Chang; Lan-Ping Xu; Kai-Yan Liu; Dai-Hong Liu; Xiao-Hui Zhang; Huan Chen; Wei Han; Yu-Hong Chen; Feng-Rong Wang; Jing-Zhi Wang; Yao Chen; Chen-Hua Yan; Ming-Rui Huo; Dan Li; Xiao-Jun Huang
Journal:  Blood       Date:  2014-06-10       Impact factor: 22.113

8.  The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation.

Authors:  C N Boyd; R C Ramberg; E D Thomas
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

9.  Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation.

Authors:  Lukasz P Gondek; Gang Zheng; Richard Jones; Christopher D Gocke; Gabriel Ghiaur; Amy E DeZern; William Matsui; Srinivasan Yegnasubramanian; Ming-Tseh Lin; Mark Levis; James R Eshleman; Ravi Varadhan; Noah Tucker
Journal:  Leukemia       Date:  2016-03-15       Impact factor: 11.528

10.  Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation.

Authors:  Silvia Mas-Peiro; Jedrzej Hoffmann; Stephan Fichtlscherer; Lena Dorsheimer; Michael A Rieger; Stefanie Dimmeler; Mariuca Vasa-Nicotera; Andreas M Zeiher
Journal:  Eur Heart J       Date:  2020-02-21       Impact factor: 29.983

View more
  5 in total

Review 1.  Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.

Authors:  Juan Bautista Menendez-Gonzalez; Neil P Rodrigues
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Clonal Hematopoiesis: From Mechanisms to Clinical Intervention.

Authors:  Thomas Köhnke; Ravindra Majeti
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 38.272

Review 3.  Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-09-01       Impact factor: 3.122

Review 4.  What to tell your patient with clonal hematopoiesis and why: insights from 2 specialized clinics.

Authors:  David P Steensma; Kelly L Bolton
Journal:  Blood       Date:  2020-10-01       Impact factor: 25.476

Review 5.  Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia.

Authors:  Sarah S Burns; Reuben Kapur
Journal:  Stem Cell Reports       Date:  2020-08-11       Impact factor: 7.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.